Skip to content

DANA Diabecare II

by Sooil Development Co., Ltd

DANA Diabecare II is an ambulatory insulin infusion pump (FDA Class II; FDA product code LZG, Pump, Infusion, Insulin) made by Sooil Development Co., Ltd, cleared under FDA 510(k) K063126 on 2 Feb 2007 and listed in FDA GUDID since 9 Jun 2023 (UDI-DI 08809220584862), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K063126

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number08809220584862 UDI-DI Date9 Jun 2023ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Special NumberK063126 Date2 Feb 2007DecidedStatusActive

Official records

From the FDA record

Device description
DANA Diabecare IIS is external programmable syringe infusion pump used for the subcutaneous delivery of insulin for the treatment of diabetes mellitus. The pump is not intended for use with blood or blood products.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K063126 decided 2 Feb 2007 Active
  • FDA GUDID UDI-DI 08809220584862 listed 9 Jun 2023 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K063126
  2. Listed FDA GUDID 08809220584862

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
DANA Diabecare
Generic name
Ambulatory insulin infusion pump, electronic, non-software-dosing
Model / reference
II
Primary DI / UDI-DI
08809220584862
510(k) Number
FDA product code
LZG
GMDN term
Ambulatory insulin infusion pump, electronic, non-software-dosing
Device class
Class II
Regulation number
880.5725
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code LZG (Pump, Infusion, Insulin).

Other devices from Sooil Development Co., Ltd.

See all devices from Sooil Development Co., Ltd. →

Properties

  • Serial number
  • Manufacturing date
Other properties (13, all answered No)